title: Clinical trials in neonates and children: Report of the pulmonary hypertension academic research consortium pediatric advisory committee.
abstract: Drug trials in neonates and children with pulmonary hypertensive vascular disease pose unique but not insurmountable challenges. Childhood is defined by growth and development. Both may influence disease and outcomes of drug trials. The developing pulmonary vascular bed and airways may be subjected to maldevelopment, maladaptation, growth arrest, or dysregulation that influence the disease phenotype. Drug therapy is influenced by developmental changes in renal and hepatic blood flow, as well as in metabolic systems such as cytochrome P450. Drugs may affect children differently from adults, with different clearance, therapeutic levels and toxicities. Toxicity may not be manifested until the child reaches physical, endocrine and neurodevelopmental maturity. Adverse effects may be revealed in the next generation, should the development of ova or spermatozoa be affected. Consideration of safe, age-appropriate tablets and liquid formulations is an obvious but often neglected prerequisite to any pediatric drug trial. In designing a clinical trial, precise phenotyping and genotyping of disease is required to ensure appropriate and accurate inclusion and exclusion criteria. We need to explore physiologically based pharmacokinetic modeling and simulations together with statistical techniques to reduce sample size requirements. Clinical endpoints such as exercise capacity, using traditional classifications and testing cannot be applied routinely to children. Many lack the necessary neurodevelopmental skills and equipment may not be appropriate for use in children. Selection of endpoints appropriate to encompass the developmental spectrum from neonate to adolescent is particularly challenging. One possible solution is the development of composite outcome scores that include age and a developmentally specific functional classification, growth and development scores, exercise data, biomarkers and hemodynamics with repeated evaluation throughout the period of growth and development. In addition, although potentially costly, we recommend long-term continuation of blinded dose ranging after completion of the short-term, double-blind, placebo-controlled trial for side-effect surveillance, which should include neurodevelopmental and peripubertal monitoring. The search for robust evidence to guide safe therapy of children and neonates with pulmonary hypertensive vascular disease is a crucial and necessary goal.
authors: Stollery Children's Hospital, University of Alberta, Edmonton, Canada.
authors: Ian
authors: I
authors: Adatia
authors: Sheila G
authors: SG
authors: Haworth
authors: Max
authors: M
authors: Wegner
authors: Robyn J
authors: RJ
authors: Barst
authors: Dunbar
authors: D
authors: Ivy
authors: Kurt R
authors: KR
authors: Stenmark
authors: Abraham
authors: A
authors: Karkowsky
authors: Erika
authors: E
authors: Rosenzweig
authors: Christopher
authors: C
authors: Aguilar
keywords: drug toxicity; pediatrics; pulmonary arterial hypertension; pulmonary hypertension with increased pulmonary vascular resistance; pulmonary vascular disease
references: Pulm Circ. 2011;1(2):286-298
references: 21874158
references: Eur Respir J. 2012 Jan;39(1):104-11
references: 21700605
references: BMC Pulm Med. 2012 Jun 07;12:23
references: 22676304
references: Circulation. 2012 Apr 17;125(15):1890-6
references: 22434595
references: N Engl J Med. 2005 Jul 7;353(1):23-32
references: 16000353
references: J Clin Epidemiol. 1996 Mar;49(3):327-33
references: 8676181
references: Prog Pediatr Cardiol. 2010 Dec 1;30(1-2):63-69
references: 21499523
references: Pediatr Blood Cancer. 2010 Jul 15;55(1):123-8
references: 20486177
references: Am Heart J. 2008 Jan;155(1):166-74
references: 18082509
references: N Engl J Med. 2003 Nov 27;349(22):2099-107
references: 14645637
references: Med Care. 2001 Aug;39(8):800-12
references: 11468499
references: Circulation. 2004 Aug 10;110(6):660-5
references: 15289375
references: Br J Clin Pharmacol. 2005 Jun;59(6):674-6
references: 15948931
references: Pulm Circ. 2011 Aug 2;1(2):280-285
references: 21874157
references: J Vasc Res. 2009;46(6):561-71
references: 19571576
references: Lancet. 2008 Jun 21;371(9630):2093-100
references: 18572079
references: Expert Opin Drug Metab Toxicol. 2011 Aug;7(8):935-48
references: 21548840
references: Lancet. 2009 Oct 17;374(9698):1310-2
references: 19837237
references: Per Med. 2011 Mar;8(2):161-173
references: 21695041
references: Br J Anaesth. 2007 May;98(5):657-61
references: 17401143
references: J Am Coll Cardiol. 2007 Feb 20;49(7):803-10
references: 17306711
references: Circulation. 2009 Jan 27;119(3):374-81
references: 19139384
references: Cardiol Res Pract. 2011;2011:965740
references: 21629801
references: Acta Paediatr. 2006 Feb;95(2):214-23
references: 16449030
references: Paediatr Drugs. 2010 Apr 1;12(2):99-103
references: 20218746
references: J Pediatr. 2009 Mar;154(3):379-84, 384.e1-2
references: 18950791
references: Handb Exp Pharmacol. 2011;205:181-202
references: 21882112
references: Circulation. 2012 Jan 17;125(2):324-34
references: 22128226
references: Circulation. 2011 Oct 18;124(16):1755-64
references: 21947294
references: Anesth Analg. 2007 Mar;104(3):521-7
references: 17312201
references: Eur Respir J. 2005 Nov;26(5):858-63
references: 16264047
references: J Pers Soc Psychol. 1986 Mar;50(3):571-9
references: 3701593
references: Lancet. 2012 Feb 11;379(9815):537-46
references: 22240409
references: Swiss Med Wkly. 2007 Sep 8;137(35-36):510-3
references: 17990138
references: Arch Cardiovasc Dis. 2010 Feb;103(2):66-74
references: 20226425
references: J Appl Physiol (1985). 1998 Jan;84(1):362-71
references: 9451658
references: Cardiol Young. 2011 Apr;21(2):187-93
references: 21138617
references: Ann Thorac Surg. 2012 Apr;93(4):1248-53
references: 22105869
references: N Engl J Med. 2006 Jul 27;355(4):343-53
references: 16870913
references: J Pediatr Psychol. 2001 Apr-May;26(3):155-62
references: 11259517
references: Congenit Heart Dis. 2012 May-Jun;7(3):259-67
references: 22325151
references: Am J Dis Child. 1992 Aug;146(8):972-6
references: 1636668
references: Proteomics Clin Appl. 2012 Jun;6(5-6):257-67
references: 22653875
references: Pediatr Pulmonol. 2004 Apr;37(4):305-10
references: 15022126
references: Pediatrics. 1983 Sep;72(3):353-5
references: 6889040
references: Br J Dis Chest. 1984 Apr;78(2):113-34
references: 6372845
references: J Pediatr. 1996 Sep;129(3):362-6
references: 8804324
references: Pediatrics. 2006 Jun;117(6):2040-6
references: 16740846
references: Am Heart J. 2011 Sep;162(3):562-8
references: 21884877
references: Ann Biomed Eng. 2009 Jun;37(6):1082-92
references: 19340571
references: Chest. 2014 Feb;145(2):237-244
references: 24030476
references: Pediatr Pulmonol. 2013 Jan;48(1):27-34
references: 22511577
references: Arch Dis Child. 2008 Jun;93(6):464-8
references: 17675356
references: Psychol Med. 1983 Aug;13(3):595-605
references: 6622612
references: Chest. 2007 Dec;132(6):1906-12
references: 17989161
references: Heart. 2010 Sep;96(17):1401-6
references: 20406768
references: Pediatr Crit Care Med. 2001 Jan;2(2):145-150
references: 12797874
references: N Engl J Med. 1960 Apr 21;262:787-94
references: 13843700
references: J Am Coll Cardiol. 2006 Feb 21;47(4):799-803
references: 16487848
references: Pediatrics. 2009 Feb;123(2):e235-8
references: 19171575
references: J Thorac Cardiovasc Surg. 2007 Nov;134(5):1179-87
references: 17976447
references: Handb Exp Pharmacol. 2011;205:125-48
references: 21882109
references: Pediatr Endocrinol Rev. 2011 Jun;8(4):364-73
references: 21972776
references: Arch Dis Child Fetal Neonatal Ed. 2009 Jul;94(4):F236-40
references: 19158148
references: Heart. 2009 Feb;95(4):312-7
references: 18952635
references: J Pediatr. 2007 Apr;150(4):395-9, 399.e1-2
references: 17382117
references: J Clin Endocrinol Metab. 2012 Feb;97(2):E213-7
references: 22238393
references: J Clin Endocrinol Metab. 2012 Feb;97(2):416-25
references: 22238382
references: Am J Respir Crit Care Med. 2007 Jul 15;176(2):174-80
references: 17463419
references: Compr Physiol. 2011 Jul;1(3):1413-35
references: 23733649
references: J Thorac Cardiovasc Surg. 2006 Mar;131(3):632-8
references: 16515916
references: Circulation. 2012 Jan 3;125(1):113-22
references: 22086881
references: Heart. 2003 Mar;89(3):311-5
references: 12591838
references: Int J Cardiol. 2009 Jun 12;135(1):21-6
references: 18599134
references: J Rheumatol. 2007 May;34(5):1125-32
references: 17444584
references: J Pediatr. 2012 Jan;160(1):111-5.e1
references: 21839472
references: Handb Exp Pharmacol. 2011;205:111-24
references: 21882108